239 results about "Brain Cell" patented technology

An ultrasonic cerebral infarction therapeutic apparatus that does not produce side effects of destruction of brain cells, occurrence of intracerebral hemorrhage, destruction of nerve cells, etc. by avoiding formation of a standing wave by interference between an irradiated beam of an ultrasonic wave irradiated to the inside of the cranium and its reflected beam. An ultrasonic probe cap is constructed by arranging a plurality of laminated small transducers each made up of a PVDF film, a PZT ceramic, or the like in a mosaic-like pattern or in other form on the inside of the cap and one or more transducers are selected and activated according to a thrombus position. As a high frequency for actuating a transducer, a continuous sinusoidal wave, a burst wave, or a pulse wave shall be used so that no standing wave may be produced inside the cranium.

DNA encoding a recombinant antibody molecule end-specific for an amyloid-beta peptide, pharmaceutical compositions thereof, and a method for preventing or inhibiting progression of Alzheimer's Disease by introducing such a DNA molecule into brain cells to express the recombinant antibody molecule and prevent the accumulation of amyloid-beta peptides in the cerebrospinal fluid.

An apparatus and method for assaying blood-brain barrier properties for drug and drug delivery vehicle screening comprising of a microfluidic apparatus with gaps separating lumen and tissue space enabling formation of tight junctions similar to in vivo conditions using endothelial cells and brain cells.

This invention provides methods for alleviating paroxysmal disorders in an animal, particularly epilepsy, by modulating glycolysis in brain cells.

The invention relates to a health care composite which consists of lecithin, grape pip extract and ginkgo leaf extract. The invention consists of the lecithin, the grape pip extract and the ginkgo leaf extract together; wherein, the lecithin accounts for 10 percent to 80 percent of the total weight, the grape pip extract accounts for 1-50 percent of the total weight and ginkgo leaf extract accounts for 1-50 percent of the total weight. The invention has the advantages that: the lecithin has the functions of nourishing the brain, improving intelligence, regulating blood lipid, eliminating fatigue, improving sleep, and so on; the grape pip extract has mighty antioxidation for the human body, can reduce erythrocyte aggregation and the permeability of capillary vessel; the ginkgo leaf extract can improve cerebrovascular circulation, protect brain cells from being damaged due to ischemia, dilate the coronary artery, prevent angina and myocardial infarction, eliminate harmful oxygen free radical, promote immunity and resist aging, and so on; the composite combined by three medicines brings convenience to consumers for oral administration and integrates three efficacies into a whole, thus enhancing the curative effect of the health care product.